12.03.2020 – Zur Rose Group AG

Zur Rose Group broadens its leadership structure and completes Group Management

Zur Rose Group AG / Key word(s): Personnel
Zur Rose Group broadens its leadership structure and completes Group

12.03.2020 / 06:45


Press release

Zur Rose Group broadens its leadership structure and completes Group

- Expansion of leadership structure in line with corporate strategy

- Focus on markets and business models reinforcing proximity to customers

- Group Management completed with appointment of David Masó as Head Europe

Zur Rose is adapting its leadership structure to the needs and opportunities
of the Group that has seen strong growth. The Board of Directors has decided
to further refine the organisation of the company with the aim of
reinforcing proximity to customers and making the organisation more agile.
In addition to the existing segment organisation with both regional and
revenue responsibility, a cross-segment business model organisation with the
following responsibilities is being put in place: Walter Hess will run the
B2B2C & B2B business model in addition to the Switzerland segment, Olaf
Heinrich will run the B2C business model in addition to the Germany segment
and David Masó will be taking on responsibility for Europe (outside Germany,
Austria and Switzerland) and the marketplace model. This will allow the Zur
Rose Group to use business model-specific expertise across countries and
profit from synergies.

The market segments and business models will be supported by two new service
units: Strategy and Digitalisation as well as Operations. As previously
announced, these will be headed by Betül Susamis Unaran as Chief Strategy
and Digital Officer and Bernd Gschaider as Chief Operations Officer with
effect from 1 May 2020. The new Group Management will thereafter consist of
seven seasoned managers. Walter Oberhänsli emphasised: "With the new,
broader leadership structure we are accelerating digitalisation initiatives
and focusing rigorously on customers. Responsibility will be spread across
several pairs of shoulders, making Zur Rose more agile and effective."

Strengthening of Group Management: David Masó to become Head Europe
As part of the new organisation, the Zur Rose Group has appointed David Masó
as Head of the Europe segment with effect from 1 May 2020. David Masó has
been CEO of the e-commerce marketplace PromoFarma in Barcelona since 2012,
which he will retain in addition to performing his Group management
function. He will also be responsible for the marketplace business model on
a Group level. David Masó founded PromoFarma, which has developed into
southern Europe's leading marketplace for consumer health, beauty and
personal care products commonly sold in pharmacies, together with Adrià
Carulla eight years ago. The two founders sold the company to the Zur Rose
Group in 2018. Before his involvement with PromoFarma David Masó co-founded
several successful e-commerce start-ups. The Spanish citizen is 48 years
old, a telecoms engineer and holds an MBA. Walter Oberhänsli is delighted at
the appointment: "David Masó is an entrepreneur with an impressive track
record. I am confident that his excellent skills in technology and
e-commerce make him the ideal person for this position, given the intended
further geographical expansion of the Zur Rose Group."

Investors and analyst contact
Marcel Ziwica, Chief Financial Officer
Email: ir@zurrose.com, phone: +41 58 810 11 49

Media contact
Lisa Lüthi, Head of Group Communications
Email: media@zurrose.com, phone: +41 52 724 08 14

19 March 2020 2019 Full-Year Results
16 April 2020 First Quarter Trading Update
23 April 2020 Annual General Meeting
19 August 2020 Half-Year Results
21 October 2020 Q3 Trading Update

Zur Rose Group

The Swiss Zur Rose Group is Europe's largest e-commerce pharmacy and one of
the leading medical wholesalers in Switzerland. It also operates the leading
marketplace in southern Europe for consumer health, beauty and personal care
products commonly sold in pharmacies. The company is internationally present
with strong brands, including Germany's best-known pharmacy brand DocMorris.
Zur Rose employs more than 1,800 people at sites in Switzerland, Germany,
the Netherlands, Spain and France. In 2019 it generated revenue of CHF 1,570
million (including medpex) and has around seven million active customers in
core European markets.

With its business model, the Zur Rose Group offers high-quality, safe and
cost-effective pharmaceutical care. It is also characterized by the
continuous further development of digital services in the field of drug
management using AI-supported applications and new technology. Zur Rose is
furthermore actively driving ahead its positioning as a comprehensive
provider of healthcare services. By creating a digital healthcare platform -
the Zur Rose ecosystem - it networks products and digital services from
qualified providers. The contribution made by Zur Rose will be to take these
offerings to customers and patients and to make a relevant selection. The
aim is to provide people with a seamless accompaniment and empower them to
manage their own health optimally using products and digital solutions.

The shares of Zur Rose Group AG are listed on the SIX Swiss Exchange
(securities number 4261528, ISIN CH0042615283, ticker ROSE). For further
information please see zurrosegroup.com.